Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade)
ContributorsThielen, A-M.; Barde, C.; Marazza, G.; Saurat, Jean-Hilaire
Published inDermatology, vol. 217, no. 2, p. 137-139
Publication date2008
Abstract
Keywords
- Acrodermatitis/diagnosis/drug therapy
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Follow-Up Studies
- Hand Dermatoses/diagnosis/drug therapy
- Humans
- Immunoglobulin G/therapeutic use
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor/therapeutic use
- Risk Assessment
- Severity of Illness Index
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha/antagonists & inhibitors/therapeutic use
Affiliation entities
Research groups
Citation (ISO format)
THIELEN, A-M. et al. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade). In: Dermatology, 2008, vol. 217, n° 2, p. 137–139. doi: 10.1159/000134613
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:1122
- DOI : 10.1159/000134613
- PMID : 18503258
Additional URL for this publicationhttp://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000134613
Journal ISSN1018-8665
